{
    "URL": "https://doi.org/10.1371/journal.pntd.0004866",
    "Published": "August 10, 2016",
    "Subject_Areas": [
        "Vaccine development",
        "Cluster trials",
        "Medical risk factors",
        "Ebola hemorrhagic fever",
        "Epidemiology",
        "Sierra Leone",
        "Liberia",
        "Viral vaccines"
    ],
    "Authors": {
        "Ibrahim Diakite": [
            "Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America"
        ],
        "Eric Q. Mooring": [
            "Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America"
        ],
        "Gustavo E. Vel\u00e1squez": [
            "Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States of America",
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America",
            "Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America"
        ],
        "Megan B. Murray": [
            "Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America",
            "Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America",
            "Division of Global Health Equity, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States of America",
            "Partners In Health, Boston, Massachusetts, United States of America"
        ]
    }
}